Cumberland Pharmaceuticals
CPIX
Cumberland Pharmaceuticals (CPIX) earnings history
Most recent quarter
- Fiscal period
- Q3 2022
- Period end
- Sep 30, 2022
- EPS actual
- −$0.03
- EPS estimate
- $0.00
- EPS surprise
- +0.00%
- Revenue surprise
- +0.00%
- Revenue
- $11.4M
- Revenue estimate
- $0.00
- Reported
- Nov 8, 2022
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2022 | Nov 8, 2022 | $0.00 | −$0.03 | +0.00% | $11.4M | SEC |
| Q2 2022 | Aug 9, 2022 | $0.00 | −$0.09 | +0.00% | $10.3M | SEC |
| Q1 2022 | May 10, 2022 | $0.00 | −$0.09 | +0.00% | $11.2M | SEC |
| Q4 2021 | Mar 8, 2022 | −$0.01 | −$0.26 | −2500.00% | $8.3M | SEC |
| Q3 2021 | Nov 9, 2021 | −$0.11 | −$0.07 | +36.36% | $8.1M | SEC |
| Q2 2021 | Aug 10, 2021 | −$0.13 | $0.08 | +161.54% | $9.1M | SEC |
| Q1 2021 | May 11, 2021 | −$0.13 | $0.01 | +107.69% | $10.5M | SEC |
| Q4 2020 | Mar 9, 2021 | −$0.06 | −$0.06 | +0.00% | $10.3M | SEC |
| Q3 2020 | Nov 10, 2020 | −$0.18 | −$0.03 | +83.33% | $9.3M | SEC |
| Q2 2020 | Aug 11, 2020 | −$0.06 | −$0.06 | +0.00% | $9.6M | SEC |
| Q1 2020 | May 20, 2020 | −$0.13 | −$0.07 | +46.15% | $8.3M | — |
Quarterly revenue
Frequently asked questions
When did Cumberland Pharmaceuticals (CPIX) last report earnings?
Cumberland Pharmaceuticals last reported on Nov 8, 2022, covering fiscal Q3 2022.
Did CPIX beat earnings estimates?
Cumberland Pharmaceuticals reported EPS of −$0.03 for Q3 2022, in line with the $0.00 consensus estimate.
How much revenue did CPIX report last quarter?
Cumberland Pharmaceuticals reported $11.4M in revenue for Q3 2022.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.